Breaking News

GreenVax Selects Xcellerex Single-Use Bioreactor

Plant-based vaccine production to use XDR systems.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Project GreenVax has agreed to acquire XDR GMP single-use production bioreactors from Xcellerex. The systems will be deployed in a new facility currently under construction in Bryan, TX. Project GreenVax is spearheaded by Texas Plant-Expressed Vaccine Consortium, which consists of G-Con, LLC and The Texas A&M University System. Financial terms were not disclosed. “The XDR system has been demonstrated to be very adaptable and effective in growing wide variety of organisms to support our pr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters